European Respiratory Society

September 14, 2016September 14, 2016

Boehringer Reports Long-term Positive Effects of IPF Therapy Ofev

Boehringer Ingelheim recently shared positive data from a clinical trial evaluating long-term treatment with Ofev (nintedanib) in idiopathic pulmonary fibrosis (IPF) patients. The interim findings from the INPULSIS-ON extension trial were ... Read more

September 15, 2014November 11, 2015

Wearable, Comfortable COPD Breathing Device Gets Key Endorsements

COPD, News

California-based Breathe Technologies was recently granted CE Certification for its Non-Invasive Open Ventilation (NIOV) System, a medical technology for patients with respiratory insufficiency diseases and neuromuscular diseases, which will allow the company to market ... Read more

September 12, 2014November 6, 2015

Pharmaxis to Present New Data on Bronchiectasis Study at European Respiratory Society

Bronchiectasis

Pharmaceutical company Pharmaxis announced that it has presented new data from its large scale study of Bronchitol, called B305, and conducted in patients with bronchiectasis, at the European Respiratory Society (ERS), which took take ... Read more

September 11, 2014November 11, 2015

New Data From GSK Shows Promising Blood Eosinophil Levels For Informing COPD Treatment Decisions

COPD, News

A team of GSK researchers recently presented at the European Respiratory Society (ERS) Congress data showing eosinophil levels in the blood may be predictors of exacerbation rates in patients with Chronic ... Read more

September 10, 2014November 6, 2015

Two GSK Phase III Studies of Mepolizumab For Severe Eosinophilic Asthma Show Promise

Asthma, News

A team of researchers at GSK recently presented the results from two-PHASE III Clinical Trials of Mepolizumab, a new humanized IL-5 antagonist monoclonal antibody, for the treatment of severe eosinophilic ... Read more